Long-term prognosis of clinically early IgA nephropathy is not always favorable

BMC Nephrology

Volumn 15, Issue 1, 2014, Pages

  Lee, Hajeong ^a   Hwang, Jin Ho ^b   Paik, Jin Ho ^c   Ryu, Hyun Jin ^a   Kim, Dong Ki ^a   Chin, Ho Jun ^c   Oh, Yun Kyu ^d   Joo, Kwon Wook ^a   Lim, Chun Soo ^d   Kim, Yon Su ^a   Lee, Jung Pyo ^d  

^a Seoul National University Hospital   (South Korea)

^b Chung Ang University College of Medicine   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

^d Seoul National University   (South Korea)

Author keywords

IgA nephropathy; Interstitial fibrosis; Progression of renal failure

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; IMMUNOGLOBULIN A; IMMUNOSUPPRESSIVE AGENT;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; BODY MASS; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CREATININE URINE LEVEL; DISEASE COURSE; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; GLOMERULUS; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOALBUMINEMIA; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN BLOOD LEVEL; INTESTINE PERFORATION; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY FUNCTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MESANGIUM CELL; MORTALITY; OGILVIE SYNDROME; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PRESCRIPTION; PROGNOSIS; PROTEIN URINE LEVEL; PROTEINURIA; REMISSION; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL; URINALYSIS; YOUNG ADULT; COMORBIDITY; EPIDEMIOLOGY; GLOMERULONEPHRITIS, IGA; LONGITUDINAL STUDY; MIDDLE AGED; RETROSPECTIVE STUDY; RISK FACTOR; SOUTH KOREA;

ADULT; CAUSALITY; COMORBIDITY; GLOMERULONEPHRITIS, IGA; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS; PROTEINURIA; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84902754455     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-15-94     Document Type: Article

References (27)

1. Mortality and renal outcome of primary glomerulonephritis in Korea: observation in 1,943 biopsied cases. Lee H, Kim DK, Oh KH, Joo KW, Kim YS, Chae DW, Kim S, Chin HJ, Am J Nephrol 2013 37 1 74 83 10.1159/000345960 23343855
2. Risk stratification of patients with IgA nephropathy. Barbour SJ, Reich HN, Am J Kidney Dis 2012 59 6 865 873 10.1053/j.ajkd.2012.02.326 22497792
3. IgA nephropathy. Wyatt RJ, Julian BA, N Engl J Med 2013 368 25 2402 2414 10.1056/NEJMra1206793 23782179
4. Mortality of IgA nephropathy patients: a single center experience over 30 years. Lee H, Kim DK, Oh KH, Joo KW, Kim YS, Chae DW, Kim S, Chin HJ, PLoS One 2012 7 12 51225 10.1371/journal.pone.0051225 23226568
5. Pathogenesis of immunoglobulin A nephropathy: recent insight from genetic studies. Kiryluk K, Novak J, Gharavi AG, Annu Rev Med 2013 64 339 356 10.1146/annurev-med-041811-142014 23072577
6. Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria. Gutiérrez E, Zamora I, Ballarín JA, Arce Y, Jiménez S, Quereda C, Olea T, Martínez-Ara J, Segarra A, Bernis C, García A, Goicoechea M, García de Vinuesa S, Rojas-Rivera J, Praga M, J Am Soc Nephrol 2012 23 10 1753 1760 10.1681/ASN.2012010063 22956820
7. Prognostic indicators of IgA nephropathy in the Chinese-clinical and pathological perspectives. Li PK, Ho KK, Szeto CC, Yu L, Lai FM, Nephrol Dial Transplant 2002 17 1 64 69 10.1093/ndt/17.1.64 11773464 (Pubitemid 34093011)
8. The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria. Szeto CC, Lai FM, To KF, Wong TY, Chow KM, Choi PC, Lui SF, Li PK, Am J Med 2001 110 6 434 437 10.1016/S0002-9343(01)00659- 3 11331053 (Pubitemid 32452329)
9. Clinical course and prognostic factors of clinical early IgA nephropathy. Shen P, He L, Huang D, Neth J Med 2002 66 6 242 247
10. Mortality in patients with IgA nephropathy. Knoop T, Vikse BE, Svarstad E, Leh S, Reisaeter AV, Bjorneklett R, Am J Kidney Dis 2013 62 5 833 890
11. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F, Ann Intern Med 2006 145 4 247 254 10.7326/0003-4819-145-4-200608150-00004 16908915 (Pubitemid 46768608)
12. Ethnic coefficients for glomerular filtration rate estimation by the Modification of Diet in Renal Disease study equations in the Korean population. Lee CS, Cha RH, Lim YH, Kim H, Song KH, Gu N, Yu KS, Lim CS, Han JS, Kim S, Kim YS, J Korean Med Sci 2010 25 11 1616 1625 10.3346/jkms.2010.25.11.1616 21060751
13. IgA Mesangial Nephropathy: Berger's Disease. Sinniah R, Am J Nephrol 1985 5 2 73 83 10.1159/000166911 3887921 (Pubitemid 15145085)
14. Current status of dialysis therapy in Korea. Jin DC, Korean J Intern Med 2011 26 2 123 131 10.3904/kjim.2011.26.2.123 21716586
15. Current status of dialytic therapy in Korea. Kim SY, Jin DC, Bang BK, Nephrology 2003 8 Suppl 2 S9 15012684
16. Characterization of early IgA Nephropathy. Lai FM, Szeto CC, Choi PC, Li PK, Chan AW, Tang NL, Lui SF, Wang AY, To KF, Am J Kidney Dis 2000 36 4 703 708 10.1053/ajkd.2000.17614 11007671
17. Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research Group on Progressive Renal Diseases. Koyama A, Igarashi M, Kobayashi M, Am J Kidney Dis 2000 29 4 526 532 (Pubitemid 27155272)
18. Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. Kiryluk K, Li Y, Sanna-Cherchi S, Rohanizadegan M, Suzuki H, Eitner F, Snyder HJ, Choi M, Hou P, Scolari F, Izzi C, Gigante M, Gesualdo L, Savoldi S, Amoroso A, Cusi D, Zamboli P, Julian BA, Novak J, Wyatt RJ, Mucha K, Perola M, Kristiansson K, Viktorin A, Magnusson PK, Thorleifsson G, Thorsteinsdottir U, Stefansson K, Boland A, Metzger M, et al. PLoS Genet 2012 8 6 1002765 10.1371/journal.pgen.1002765 22737082
19. Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal disease. Barbour SJ, Cattran DC, Kim SJ, Levin A, Wald R, Hladunewich MA, Reich HN, Kidney Int 2013 84 5 1017 1024 10.1038/ki.2013.210 23739233
20. Pathophysiology of progressive nephropathies. Remuzzi G, Bertani T, N Engl J Med 1998 339 20 1448 1456 10.1056/NEJM199811123392007 9811921 (Pubitemid 28516069)
21. Tubular lesions determine prognosis of IgA nephropathy. Daniel L, Saingra Y, Giorgi R, Bouvier C, Pellissier JF, Berland Y, Am J Kidney Dis 2000 35 1 13 20 10.1016/S0272-6386(00)70295-2 10620538 (Pubitemid 30027234)
22. Pathogenesis of IgA nephropathy. Lai KN, Nat Rev Nephrol 2012 8 5 275 283 10.1038/nrneph.2012.58 22430056
23. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D'Agati V, D'Amico G, Emancipator S, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, et al. Kidney Int 2009 76 5 534 545 10.1038/ki.2009.243 19571791
24. The Oxford classification as a predictor of prognosis in patients with IgA nephropathy. Kang SH, Choi SR, Park HS, Lee JY, Sun IO, Hwang HS, Chung BH, Park CW, Yang CW, Kim YS, Choi YJ, Choi BS, Nephrol Dial Transplant 2012 27 1 252 258 10.1093/ndt/gfr295 21606384
25. Predicting progression of IgA nephropathy: new clinical progression risk score. Xie J, Kiryluk K, Wang W, Wang Z, Guo S, Shen P, Ren H, Pan X, Chen X, Zhang W, Li X, Shi H, Li Y, Gharavi AG, Chen N, PLoS One 2012 7 6 38904 10.1371/journal.pone.0038904 22719981
26. A predictive model for progression of chronic kidney disease to kidney failure. Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, Levin A, Levey AS, JAMA 2011 305 15 1553 1559 10.1001/jama.2011.451 21482743
27. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. Keane WF, Brenner BM, De Zeeuw D, Grunfeld JP, McGill J, Mitch WE, Ribeiro AB, Shahinfar S, Simpson RL, Snapinn SM, Toto R, Kidney Int 2003 63 4 1499 1507 10.1046/j.1523-1755.2003.00885.x 12631367 (Pubitemid 36350016)